Portillo-Romero Alejandra Jalil, León-Maldonado Leith, Allen-Leigh Betania, Brown Brandon, Magis Carlos, García-Fuentes Norma Beatriz, Salmerón Jorge, Hurtado Erika, Torres-Ibarra Leticia, Rivera-Paredez Berenice, Hernández-López Rubí, Yunes-Díaz Elsa, Lazcano-Ponce Eduardo
Instituto Nacional de Salud Pública. Cuernavaca, Mexico.
Conacyt- Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Mexico City, Mexico.
Salud Publica Mex. 2018 Nov-Dic;60(6):658-665. doi: 10.21149/10182.
To measure HPV vaccine acceptance in diverse Mexican adult popula-tions, taking into account HIV status.
A total of 1 329 men and women, with and without HIV, participated in one of three intervention studies, offering HPV vaccination, carried out in the states of Morelos, Tlaxcala and Mexico City; either the bivalent (Morelos n=103, Tlaxcala n=127) or quadrivalent HPV-vaccine (Mexico City n=1 099) was offered.
HPV vaccine was accepted by 80.3% of participants; acceptance was higher in people living with HIV than those without (84.4 vs. 78%, p=0.004). Women had greater HPV infection knowledge (p<0.0001) than men and slightly higher (p=0.4) vaccine acceptance. The main reason for vaccine non-acceptance among HIV-positive participants was their doctor recommended they not get vaccinated.
Acceptance of HPV-vaccine was high in men and women regardless of HIV status. Even higher rates of acceptability may be achieved by educating healthcare providers to recommend HPV vaccine to their patients.
考虑到艾滋病毒感染状况，测量墨西哥不同成年人群对人乳头瘤病毒（HPV）疫苗的接受程度。
共有1329名男性和女性，包括感染艾滋病毒和未感染艾滋病毒的，参与了在莫雷洛斯州、特拉斯卡拉州和墨西哥城开展的三项干预研究之一，这些研究提供HPV疫苗接种；提供的疫苗为二价HPV疫苗（莫雷洛斯州n = 103，特拉斯卡拉州n = 127）或四价HPV疫苗（墨西哥城n = 1099）。
80.3%的参与者接受了HPV疫苗；艾滋病毒感染者的接受率高于未感染者（84.4%对78%，p = 0.004）。女性对HPV感染的了解程度高于男性（p < 0.0001），疫苗接受率略高（p = 0.4）。艾滋病毒阳性参与者中不接受疫苗的主要原因是他们的医生建议他们不要接种疫苗。
无论艾滋病毒感染状况如何，男性和女性对HPV疫苗的接受程度都很高。通过教育医疗服务提供者向患者推荐HPV疫苗，可能会实现更高的接受率。
